CD86 and Hyperglycemia: Hence, the administration of a slow-releasing H2S donor, GYY-4137, downregulated the expression of M1 markers (i.e., iNOS, CD11c, and CD86) elicited by LPS under our in vitro approach of hyperglycaemia.